TABLE 5.
Predictors of Postoperative ICHa
| Variable | OR | 95% CI | P Value |
|---|---|---|---|
| Age >60 y | 2.66 | 1.36-5.18 | <.01 |
| Male sex | 1.22 | 0.63-2.36 | |
| Comorbidities | |||
| Smoker | 0.93 | 0.43-1.98 | |
| Coronary artery disease | 0.83 | 0.30-2.26 | |
| Vascular disease | 1.30 | 0.65-2.59 | |
| HIV | 1.07 | 0.09-12.04 | |
| Previous cancer diagnosis | 1.31 | 0.69-2.51 | |
| Medications on consultation | |||
| Aspirin | 2.51 | 1.23-5.28 | <.05 |
| Clopidogrel | 0.83 | 0.16-4.43 | |
| Warfarin | 0.84 | 0.16-4.47 | |
| NSAIDs | 0.29 | 0.03-2.41 | |
| Steroids | 1.26 | 0.64-2.48 | |
| Imaging and clinical studies | |||
| Focal lesion on CT scan | 2.19 | 0.91-5.29 | |
| Focal lesion on MRI | 1.33 | 0.65-2.72 | |
| Enhancing lesion on MRI | 2.00 | 1.01-3.99 | |
| Catheter angiography performed | 0.52 | 0.23-1.14 | |
| CT angiography performed | 2.07 | 0.13-33.8 | |
| MR angiography performed | 0.32 | 0.11-0.99 | <.05 |
| Vasculitis/vasculopathy on angiography | 0.44 | 0.09-2.09 | |
| Surgical technique | |||
| Biopsy of specific lesion on MRI | 1.87 | 0.90-3.90 | |
| Image-guided surgery | 1.58 | 0.77-3.24 |
a
ICH, intracranial hemorrhage; OR, odds ratio; CI, confidence interval; HIV, human immunodeficiency virus; NSAIDs, nonsteroidal anti-inflammatory drugs; CT, computed tomography; MRI, magnetic resonance imaging.